Skip to main content

Table 3 Binary logistic regression for PDNV vs no PDNV

From: Postoperative and postdischarge nausea and vomiting following ambulatory eye, head, and neck surgeries: a retrospective cohort study comparing incidence and associated factors

Comparison

Outcome: PDNV vs. no PDNV

AOR (95% CI)

p value

Patient characteristics

 Age (per 1 year increase)

0.99 (0.98, 1)

0.002

 Male sex

0.63 (0.51, 0.76)

 < 0.001

ASA

 2 vs 1

0.99 (0.77, 1.27)

0.945

 3 vs 1

1.02 (0.69, 1.49)

0.935

 3 vs 2

1.02 (0.75, 1.4)

0.876

Body mass index (per 1 kg/m2 increase)

0.98 (0.96, 0.99)

0.012

Current smoker

0.74 (0.51, 1.08)

0.115

Otolaryngology service ( vs. ophthalmology)

0.87 (0.66, 1.14)

0.319

Pre/intraoperative anesthesia characteristics

 Total anesthesia time (per 1 min increase)

1 (1, 1)

0.276

 Inhalational time (per 1 min increase)

1 (1, 1)

0.77

 Nitrous time (per 1 min increase)

1 (1, 1)

0.839

 Propofol-only TIVA

0.62 (0.41, 0.94)

0.025

Pre/intraoperative/PACU anesthesia characteristics

 PACU phase 1 time (per 1 min increase)

1 (1, 1)

0.938

 PACU phase 2 time (per 1 min increase)

1 (1, 1)

 < 0.001

Number of antiemetics used

 1 vs. 0

0.84 (0.35, 1.98)

0.683

 2 vs. 0

0.88 (0.38, 2.01)

0.757

 3 vs. 0

0.67 (0.28, 1.59)

0.363

 4 vs. 0

0.2 (0.05, 0.84)

0.028

Opioid use (per 1 MME increase)

1.01 (1, 1.01)

< 0.001

PONV

2.79 (2.24, 3.46)

< 0.001

  1. Variables related to antiemetic and opioid drug use include all drugs administered intraoperatively and in the PACU. The antiemetics used variable includes ondanestron, scopolamine, dexamethasone, and promethazine Abbreviations: N/V nausea/vomiting, PONV postoperative nausea/vomiting, PDNV postdischarge nausea/vomiting, AOR adjusted odds ratio, ASA American Society of Anesthesiologists, TIVA total intravenous anesthesia, MME morphine milligram equivalents